Results 1 to 10 of about 16,917 (221)

ARFID Triggered by Dysgeusia: A Case Report on Light Therapy, Nutritional Support, and Mirtazapine [PDF]

Clinical Case Reports
Here, we describe an older man who developed avoidant‐restrictive food intake after an acute onset of dysgeusia that persisted for nearly two years. After initiating a multifactorial treatment approach that included light therapy, nutritional support ...
Aanika Kashyap, Tobi Abibat Saliu, Carrie J. McAdams   +2 more
doaj   +3 more sources

Case report: Depression in an older patient with dysgeusia as the initial symptom [PDF]

Frontiers in Psychiatry
IntroductionDepression is the most common mental illness among older adults, with substantial and persistent mood depression as the main clinical feature, which is unfavorable for improvement.
Longrun Guo, Zhufa He
exaly   +4 more sources

Acupuncture in chemotherapy-induced dysgeusia (AcuDysg): study protocol of a randomised controlled trial [PDF]

BMJ Open, 2023
Introduction Dysgeusia is a common side effect of chemotherapy in patients with cancer, but to date, there is no effective treatment. Many patients with cancer request complementary medicine treatment in addition to their cancer treatments, and ...
Jürgen Barth, Claudia M Witt, Stephanie Roll, Christine Huber, Linxin Zhang, Marc Schlaeppi, Twyla Müller, Petra Voiss, Christoph Driessen   +8 more
doaj   +3 more sources

Dysosmia and dysgeusia in patients with COVID-19 in northern Taiwan

Journal of the Formosan Medical Association, 2021
Background/Purpose: To investigate the characteristics of dysosmia and dysgeusia among patients diagnosed with coronavirus disease 2019 (COVID-19) in Taiwan.
Shan-Chwen Chang, Jann-Tay Wang, Wang-Huei Sheng   +2 more
exaly   +3 more sources

Anosmia, Dysgeusia, and Comorbidity in COVID-19 Patients with Respiratory Tract Manifestations

Jurnal Respirasi, 2023
Introduction: Olfactory and special sensory disturbances such as anosmia and dysgeusia have been found among COVID-19 patients. These manifestations may cause post-covid sequelae, disturbing patients' quality of life who have recovered from COVID-19 ...
Jason Lefranda Jocelino Siswanto, Viskasari Pintoko Kalanjati, Soetjipto Soetjipto, Azlin Muhammad Mohd Yasin   +3 more
doaj   +2 more sources

Anosmia and dysgeusia in SARS-CoV-2 infection: incidence and effects on COVID-19 severity and mortality, and the possible pathobiology mechanisms - a systematic review and meta-analysis [version 1; peer review: 2 approved, 1 approved with reservations]

F1000Research, 2021
Background: The present study aimed to determine the global prevalence of anosmia and dysgeusia in coronavirus disease 2019 (COVID-19) patients and to assess their association with severity and mortality of COVID-19. Moreover, this study aimed to discuss
Endang Mutiawati, Marhami Fahriani, Sukamto S. Mamada, Jonny Karunia Fajar, Andri Frediansyah, Helnida Anggun Maliga, Muhammad Ilmawan, Talha Bin Emran, Youdiil Ophinni, Ichsan Ichsan, Nasrul Musadir, Ali A. Rabaan, Kuldeep Dhama, Syahrul Syahrul, Firzan Nainu, Harapan Harapan   +15 more
doaj   +1 more source

Taste disturbance post-tonsillectomy improved with zinc supplementation

Otolaryngology Case Reports, 2021
Objective: To discuss taste disturbance after tonsillectomy and the role of zinc therapy in the treatment of post-tonsillectomy dysgeusia. Methods: We herein report a rare presentation of dysgeusia after an uncomplicated tonsillectomy in an 11-year-old ...
Tyler A. Janz, MD, Nishat A. Momin, MD, Kirav P. Patel, BS, Shiva P. Daram, MD, Wasyl Szeremeta, MD, Harold S. Pine, MD   +5 more
doaj   +1 more source

Effect of zinc supplementation in patients with cirrhosis and dysgeusia

Annals of Hepatology, 2022
Introduction and Objective: The prevalence of dysgeusia in patients with cirrhosis is higher than 50%; the aim of the study was to evaluate the effect of zinc supplementation in patients with cirrhosis and dysgeusia.
E. Juárez-Hernández, I. López-Méndez, M. Uribe, N. Chávez-Tapia   +3 more
doaj   +1 more source

Development of a Patient-Reported Outcome Measure (PROM) for Dysgeusia During Treatment With Smoothened (SMO) Inhibitors for Basal Cell Carcinomas: The SMO-iD Questionnaire

Dermatology Practical & Conceptual, 2023
  Introduction: Dysgeusia may occur during conventional or target-therapies and affect patients adherence-to-treatment. Therefore, it should be monitored to improve clinical outcome.
Elisa Camela, Alessia Villani, Sonia Sofia Ocampo Garza, Claudia Costa, Gabriella Fabbrocini, Matteo Megna, Luca Potestio, Angelo Ruggiero, Massimiliano Scalvenzi   +8 more
doaj   +1 more source

Impact of Oral Cavity Dosimetry on Patient Reported Xerostomia and Dysgeusia in the Setting of Deintensified Chemoradiotherapy

Advances in Radiation Oncology, 2022
Purpose: To determine the relationship between mean oral cavity (OC) dose (treated as a singular organ at risk) to patient reported xerostomia and dysgeusia.
David V. Fried, PhD, Shiva K. Das, PhD, Colette Shen, MD, PhD, Lawrence B. Marks, MD, Bhishamjit S. Chera, MD   +4 more
doaj   +1 more source